TURNING DISCOVERY INTO RECOVERY

pharmaceuticals and pharmaceutical products for treating muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (rn a)-b Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceuticals and pharmaceutical products for treating muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RN A)-based therapies; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression.

Class [42]
Computer & Software Services & Scientific Services

Medical and scientific research services, namely, medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies.

Class [44]
Medical, Beauty & Agricultural Services

Providing a website and information in the field of rare and infectious diseases; providing a website and information in the field of the diagnosis and treatment of muscular dystrophy and Duchenne muscular dystrophy; providing a website and information in the field of medicine via electronic and optical communications networks.

Mark Details

Serial Number

UK00912421327

Mark Type

Word

Kind of mark

Individual